|
1 Indications And Usage Fluoxetine Is Indicated For The Treatment Of: Major Depressive Disorder (mdd). The Efficacy Of Fluoxetine In Mdd Was Established In One 5-Week Trial, Three 6-Week Trials, And One Maintenance Study In Adults. The Efficacy Of Fluoxetine Was Also Established In Two 8- To 9-Week Trials In Pediatric Patients 8 To 18 Years Of Age [see Clinical Studies (14.1) ]. Obsessions And Compulsions In Patients With Obsessive Compulsive Disorder (ocd). The Efficacy Of Fluoxetine In Ocd Was Demonstrated In Two 13-Week Trials In Adults And One 13-Week Trial In Pediatric Patients 7 To 17 Years Of Age [see Clinical Studies (14.2) ]. Binge-Eating And Vomiting Behaviors In Patients With Moderate To Severe Bulimia Nervosa. The Efficacy Of Fluoxetine In Bulimia Nervosa Was Demonstrated In Two 8-Week Trials And One 16-Week Trial In Adults [see Clinical Studies (14.3) ]. Panic Disorder, With Or Without Agoraphobia. The Efficacy Of Fluoxetine In Panic Disorder Was Demonstrated In Two 12-Week Trials In Adults [see Clinical Studies (14.4) ]. Fluoxetine Is A Selective Serotonin Reuptake Inhibitor (ssri ) Indicated For The Treatment Of: Major Depressive Disorder (mdd) ( 1 ) Adults: Efficacy Was Established In One 5-Week Trial, Three 6-Week Trials, And One Maintenance Study ( 14.1 ) Pediatrics: Efficacy Was Established In Two 8- To 9- Week Trials Of Patients Aged 8 To 18 Years ( 14.1 ) Obsessive Compulsive Disorder (ocd) ( 1 ) Adults: Efficacy Was Established In Two 13-Week Trials ( 14.2 ) Pediatrics: Efficacy Was Established In One 13-Week Trial In Patients Aged 7 To 17 Years ( 14.2 ) Bulimia Nervosa ( 1 ) Adults: Efficacy Was Established In Two 8-Week Trials And One 16-Week Trial ( 14.3 ) Panic Disorder, With Or Without Agoraphobia ( 1 ) Adults: Efficacy Was Established In Two 12-Week Trials ( 14.4 )
|